The National Cancer Institute (NCI) Cancer Moonshot Initiative
Agreement
Elsevier and the NCI Cancer Moonshot Initiative 打開新的分頁／視窗 at the National Institutes of Health have established an agreement that ensures that authors publishing in Cell Press journals can comply with the NCI’s Cancer Moonshot Initiative’s public access policy requirements.
To comply with the Cancer Moonshot Initiative’s public access policy 打開新的分頁／視窗, authors funded by this initiative can choose to publish research papers arising from it under gold open access in all Cell Press journals, in addition to other open access and hybrid titles. When publishing Gold open access, the corresponding author will be given a choice of two Creative Commons licenses.
An article publication charge (APC) is required to be paid in order to make an article open access. For further information, please refer to the guide for authors on the journal home page, or this page 打開新的分頁／視窗 for current information on Cell Press APCs.
Elsevier will deposit the final Published Journal Article in PubMed Central (PMC) on behalf of the author(s) upon publication. The version that appears in PMC will contain a CrossMark logo, the end user license and a DOI link to the final version of the article hosted on ScienceDirect 打開新的分頁／視窗. Please see our sharing policy for more information.
Help and support
Read the open access policy 打開新的分頁／視窗 of the NIH NCI Cancer Moonshot Initiative
Please refer to our sharing policy for more information
Learn more about open access publishing at Cell Press 打開新的分頁／視窗